X-Square Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.91M | Buy |
15,674
+133
| +0.9% | +$24.7K | 1.05% | 30 |
|
|
2025
Q1 | $3.26M | Buy |
15,541
+689
| +5% | +$144K | 1.4% | 18 |
|
|
2024
Q4 | $2.64M | Buy |
14,852
+142
| +1% | +$25.2K | 1.08% | 31 |
|
|
2024
Q3 | $2.91M | Buy |
14,710
+625
| +4% | +$123K | 1.28% | 26 |
|
|
2024
Q2 | $2.42M | Sell |
14,085
-171
| -1% | -$29.3K | 1.12% | 30 |
|
|
2024
Q1 | $2.51M | Buy |
14,256
+8,981
| +170% | +$1.58M | 1.19% | 29 |
|
|
2023
Q4 | $817K | Buy |
5,275
+1,051
| +25% | +$163K | 0.45% | 73 |
|
|
2023
Q3 | $569K | Hold |
4,224
| – | – | 0.38% | 82 |
|
|
2023
Q2 | $569K | Buy |
4,224
+1,950
| +86% | +$263K | 0.38% | 82 |
|
|
2023
Q1 | $362K | Buy |
2,274
+8
| +0.4% | +$1.27K | 0.21% | 113 |
|
|
2022
Q4 | $366K | Buy |
+2,266
| New | +$366K | 0.21% | 119 |
|